Hernia Mesh

⚠ BORDERLINE MATURE / SETTLEMENT 2 signals
Mesh Failure, Adhesion, Perforation  ·  Polypropylene Hernia Mesh
DEFENDANT
Bard / Davol / Ethicon / Covidien
MDL / DOCKET
MDL 2846 (Bard)
S.D. Ohio
JUDGE
Hon. Edmund Sargus
PLAINTIFFS
35,000+
BELLWETHER / TRIAL
Completed
SETTLEMENT STATUS
Multiple defendant settlements
📋 Case Overview

Polypropylene hernia mesh products from multiple manufacturers have caused serious complications including adhesions, perforations, infections, and mesh migration. The major MDLs are in mature or settlement phases. C.R. Bard/Davol, Ethicon/J&J, and Covidien/Medtronic have all faced mass tort claims. New cases from recent revision surgeries may still qualify under the discovery rule.

⚗ CAUSATION SUMMARY

Polypropylene mesh degrades, shrinks, and stiffens after implantation, causing chronic pain, recurrence, bowel obstruction, and erosion into adjacent structures. The injury mechanism is well-established through bellwether trials and expert testimony. Strongest remaining cases involve recent revision surgeries and specific high-risk mesh products.

⚖️ Litigation Status DECLINING — MATURE MDL
MDL / Court
MDL 2846 (Bard) — Mature/Settlement | Multiple other MDLs
Active Plaintiffs
35,000+

The major hernia mesh MDLs are in settlement or wind-down phases. Bard/Davol has resolved thousands of cases. Ethicon and Covidien settlements ongoing. New cases limited to recent revision surgeries.

Key Verdicts & Settlements
⚖️
Multiple Bard bellwether verdicts — plaintiff wins (2019–2022)
Series of bellwether trials drove Bard to negotiate global resolution. Established strong liability framework.
💰
Multi-billion Bard/Davol global settlement (2022)
Covers majority of MDL 2846 inventory. Specific terms not publicly disclosed.
💰
Ethicon Physiomesh settlements (2020–ongoing)
Following 2016 product recall. Settlement values range widely based on injury severity.
📉
Filing trend: Declining. Mature MDL — bulk of claims resolved. New campaigns limited to recent revision surgeries. Attorneys should screen carefully for recent revision surgeries.
📍 Geographic Exposure
Nationwide
MDL 2846 (Bard) in S.D. Ohio; multiple other MDLs in S.D. West Virginia
No geographic restriction
🏢 Key Defendants
DEFENDANT
ROLE
INTEL NOTE
C.R. Bard / Davol (BD)
Primary defendant
MDL 2846; multiple billion-dollar settlements
Ethicon / Johnson & Johnson
Major defendant
Physiomesh recalled 2016; significant settlements
Covidien / Medtronic
Major defendant
Parietex and other products; active cases
Atrium Medical
Manufacturer
C-QUR fish oil-coated mesh MDL
✅ Campaign Eligibility Criteria
Hernia mesh implant surgery after 2000
Subsequent revision surgery to remove or repair mesh
Documented complications: infection, migration, adhesion, perforation, or chronic pain
Revision surgery within applicable filing window (2–4 years from revision)
These criteria reflect general case strength indicators and are not legal advice. Contact CloudIntake to screen individual claimants.
📅 Litigation Timeline
2016
Ethicon recalls Physiomesh following registry data showing high complication rates
2018
MDL 2846 (Bard) formed in S.D. Ohio
2020–2023
Multiple bellwether verdicts and settlements with major manufacturers
2023
Most major MDLs in settlement or wind-down phase
2024
New claims from recent revision surgeries still viable under discovery rule
Hernia Mesh — Intelligence Feed LIVE
📰 NEWS
Hernia Mesh Lawsuit Against C.R.
Bard
Mar 13, 2026 Lawsuit Information Center Read Source →
📰 NEWS
2026 Update: Hernia Mesh Patch Lawsuit & Compensation Info
Mar 13, 2026 Schmidt & Clark, LLP Read Source →
Feed All Torts
MASS TORT AD AGENCY
Same tort. Better creative. Lower CPL.
The Hernia Mesh market is saturated with generic ads. MTAA’s proprietary creative approach finds the angles your competitors miss.
Get a Creative Review →
Plaintiff attorneys only · mtaa.ai
JACOB SCORE™
Hernia Mesh
67 / 100
ScienceModerate
MomentumModerate
CampaignModerate
TimelineModerate
VerdictsStrong
LARGE SETTLEMENTS · MATURE MDL
Jacob Score™ — Methodology & Legal Disclaimers
The Jacob Score is a composite 1–100 litigation opportunity index for mass torts, produced by the TortIntel editorial team at Mass Tort Ad Agency. It is updated periodically as litigation conditions change.

Score Dimensions (each rated 1–5)

Science — Peer-reviewed study quality and quantity, relative risk magnitude, replication across independent research groups, FDA or regulatory action taken, and estimated Daubert survivability based on published expert testimony and prior rulings.

Momentum — MDL formation and phase, plaintiff count trajectory, case consolidation activity, and overall litigation velocity.

Campaign — Current filing window status, case saturation, defendant solvency, estimated qualifying population size, and co-defendant dynamics.

Timeline — Proximity to first expected resolution or bellwether trial, current discovery or Daubert phase, and estimated time-to-value for a signed plaintiff.

Verdicts — Confirmed plaintiff jury verdicts, bellwether trial win/loss record, and size or certainty of any established settlement fund. 1 = pre-trial · 2 = mixed early results · 3 = partial settlements or initial wins · 4 = confirmed large verdicts or funded settlement · 5 = landmark verdicts with formal settlement program.

LEGAL DISCLAIMERS

The Jacob Score and all associated content on TortIntel.ai is provided solely for mass tort business intelligence and law firm marketing decision-making purposes. It does not constitute legal advice, litigation strategy advice, or a recommendation to file or refrain from filing any lawsuit.

The Jacob Score is an editorial opinion based on publicly available data including court filings, published scientific literature, regulatory actions, and reported settlement information. It is not a guarantee of future litigation outcomes. Past verdicts and settlements are not predictive of future results in any specific case.

TortIntel.ai and Mass Tort Ad Agency make no representation that any score is complete, accurate, or current. Litigation conditions change rapidly. Attorneys must conduct independent due diligence and consult qualified co-counsel before making any case acquisition or litigation funding decisions based on this or any other intelligence tool.

This score must not be used to evaluate, accept, or reject any individual plaintiff’s case. Case-specific merit depends on individual facts, applicable state law, expert medical and scientific analysis, and jurisdiction-specific statutes of limitations — all of which are beyond the scope of this tool.

No attorney-client relationship is created by use of this platform. TortIntel.ai is not a law firm and does not provide legal services. © 2026 Mass Tort Ad Agency / TortIntel.ai. All rights reserved.
DATA ACCURACY
See something incorrect? Reach out and we'll fix it.
🔔 Alert Me
Get notified when Hernia Mesh updates.
✓ You're subscribed. We'll notify you of key developments.
TORTINTEL PRO
Abuse Discovery Tracker
Emerging institutional abuse cases — church, scouting, youth programs. Real-time defendant monitoring, filing window alerts, and filing cluster detection.
View Pro Features →